Philippe Gautret

InstitutionAix Marseille Univ
AddressMarseille
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 67 Covid-19 publications, with a maximum of 13 publications in January 2021
    All Publications
    Bar chart showing 650 publications over 28 distinct years, with a maximum of 53 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Colson P, Devaux CA, Lagier JC, Gautret P, Raoult D. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15). PMID: 34362060.
      Citations: 2     
    2. Giraud-Gatineau A, Gautret P, Colson P, Chaudet H, Raoult D. Evaluation of Strategies to Fight COVID-19: The French Paradigm. J Clin Med. 2021 Jun 30; 10(13). PMID: 34209087.
      Citations:    
    3. Gautret P, Houhamdi L, Nguyen NN, Hoang VT, Giraud-Gatineau A, Raoult D. Does SARS-CoV-2 re-infection depend on virus variant? Clin Microbiol Infect. 2021 09; 27(9):1374-1375. PMID: 34197931.
      Citations: 1     Fields:    Translation:Humans
    4. Dao TL, Hoang VT, Colson P, Lagier JC, Million M, Raoult D, Levasseur A, Gautret P. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12). PMID: 34203844.
      Citations: 2     
    5. Osman IO, Melenotte C, Brouqui P, Million M, Lagier JC, Parola P, Stein A, La Scola B, Meddeb L, Mege JL, Raoult D, Devaux CA. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732. PMID: 34194422.
      Citations: 5     Fields:    Translation:HumansCells
    6. Petersen E, Schlagenhauf P, Lee SS, Blumberg L, Kramer L, Obiero C, Al-Abri S, Cunha F, Petrosillo N, Di Caro A, Gautret P, Shafi S, Abubakar A, Pinto TCA, Memish Z, Hui DSC, Zumla A, Grobusch MP. Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics. Int J Infect Dis. 2021 07; 108:156-158. PMID: 34089881.
      Citations:    Fields:    
    7. Hoang VT, Goumballa N, Al-Tawfiq JA, Sokhna C, Gautret P. Tokyo olympics, Hajj pilgrimage, Grand Magal of Touba and COVID-19. Travel Med Infect Dis. 2021 Jul-Aug; 42:102088. PMID: 34052405.
      Citations:    Fields:    Translation:Humans
    8. Dao TL, Hoang VT, Nguyen NN, Delerce J, Chaudet H, Levasseur A, Lagier JC, Raoult D, Colson P, Gautret P. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6. PMID: 34044152.
      Citations: 4     Fields:    Translation:Humans
    9. Finance J, Zieleskewicz L, Habert P, Jacquier A, Parola P, Boussuges A, Bregeon F, Eldin C. Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19. J Clin Med. 2021 May 19; 10(10). PMID: 34069557.
      Citations: 2     
    10. Drancourt M, Cortaredona S, Melenotte C, Amrane S, Eldin C, La Scola B, Parola P, Million M, Lagier JC, Raoult D, Colson P. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5). PMID: 34065871.
      Citations: 2     Fields:    Translation:Humans
    11. Fournier PE, Colson P, Levasseur A, Devaux CA, Gautret P, Bedotto M, Delerce J, Brechard L, Pinault L, Lagier JC, Fenollar F, Raoult D. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236. PMID: 33785459.
      Citations: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    12. Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537. PMID: 33675046.
      Citations: 10     Fields:    Translation:Humans
    13. Edouard S, Jaafar R, Orain N, Parola P, Colson P, La Scola B, Fournier PE, Raoult D, Drancourt M. Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1309-1317. PMID: 33660134.
      Citations: 6     Fields:    Translation:Humans
    14. Hache G, Rolain JM, Gautret P, Deharo JC, Brouqui P, Raoult D, Honoré S. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290. PMID: 33729874.
      Citations: 2     Fields:    Translation:Humans
    15. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21. PMID: 33594500.
      Citations:    
    16. Gautret P, Hoang VT, Colson P, Raoult D. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. Int J Antimicrob Agents. 2021 Mar; 57(3):106306. PMID: 33596459.
      Citations:    Fields:    Translation:Humans
    17. Ly TDA, Hoang VT, Goumballa N, Louni M, Canard N, Dao TL, Medkour H, Borg A, Bardy K, Esteves-Vieira V, Filosa V, Davoust B, Mediannikov O, Fournier PE, Raoult D, Gautret P. Variations in respiratory pathogen carriage among a homeless population in a shelter for men in Marseille, France, March-July 2020: cross-sectional 1-day surveys. Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1579-1582. PMID: 33580843.
      Citations: 2     Fields:    Translation:HumansCells
    18. Ly TDA, Nguyen NN, Hoang VT, Goumballa N, Louni M, Canard N, Dao TL, Medkour H, Borg A, Bardy K, Esteves-Vieira V, Filosa V, Davoust B, Mediannikov O, Fournier PE, Raoult D, Gautret P. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020. Int J Infect Dis. 2021 Apr; 105:1-6. PMID: 33578010.
      Citations: 5     Fields:    Translation:Humans
    19. Honoré S, Gautret P. Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients. Travel Med Infect Dis. 2021 Mar-Apr; 40:101984. PMID: 33549822.
      Citations:    Fields:    Translation:Humans
    20. Colson P, Levasseur A, Gautret P, Fenollar F, Thuan Hoang V, Delerce J, Bitam I, Saile R, Maaloum M, Padane A, Bedotto M, Brechard L, Bossi V, Ben Khedher M, Chaudet H, Million M, Tissot-Dupont H, Lagier JC, Mboup S, Fournier PE, Raoult D. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980. PMID: 33535105.
      Citations: 12     Fields:    Translation:Humans
    21. Sokhna C, Goumballa N, Hoang VT, Bassene H, Parola P, Gautret P. The Grand Magal of Touba was spared by the COVID-19 pandemic. Int J Infect Dis. 2021 Apr; 105:470-471. PMID: 33434665.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    22. Nguyen NN, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun; 27(6):931-932. PMID: 33418020.
      Citations: 11     Fields:    Translation:Humans
    23. Gautret P, Lagier JC, Honoré S, Hoang VT, Colson P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243. PMID: 33408014.
      Citations: 2     Fields:    Translation:Humans
    24. Gautret P, Hoang VT, Chaudet H, Lagier JC, Raoult D. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244. PMID: 33408015.
      Citations:    Fields:    Translation:Humans
    25. Million M, Roussel Y, Gautret P, Raoult D. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. Int J Antimicrob Agents. 2021 Jan; 57(1):106240. PMID: 33408019.
      Citations: 1     Fields:    Translation:Humans
    26. Gautret P, Honoré S, Lagier JC, Raoult D. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236. PMID: 33408025.
      Citations: 1     Fields:    Translation:Humans
    27. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237. PMID: 33408027.
      Citations:    Fields:    Translation:Humans
    28. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235. PMID: 33408028.
      Citations:    Fields:    Translation:Humans
    29. Gautret P, Hoang VT, Lagier JC, Raoult D. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239. PMID: 33408029.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    30. Colson P, La Scola B, Lagier JC, Gautret P, Raoult D. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238. PMID: 33408030.
      Citations:    Fields:    Translation:Humans
    31. Gautret P, Hoang VT, Honoré S, Roussel Y, Million M, Lagier JC, Raoult D. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241. PMID: 33408031.
      Citations: 1     Fields:    Translation:Humans
    32. Gautret P, Lagier JC, Honoré S, Hoang VT, Raoult D. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242. PMID: 33408033.
      Citations: 1     Fields:    Translation:Humans
    33. Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184. PMID: 33356661.
      Citations: 19     Fields:    Translation:Humans
    34. Boschi C, Hoang VT, Giraud-Gatineau A, Ninove L, Lagier JC, La Scola B, Gautret P, Raoult D, Colson P. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881. PMID: 33230812.
      Citations: 4     Fields:    Translation:HumansCells
    35. Million M, Giraud-Gatineau A, Lagier JC, Parola P, Gautret P, Raoult D. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis. 2021 Jan-Feb; 39:101954. PMID: 33316396.
      Citations: 1     Fields:    Translation:Humans
    36. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117. PMID: 33201409.
      Citations: 4     
    37. Goumballa N, Dieng M, Sokhna C, Gautret P. Lack of SARS-CoV-2 among Grand Magal de Touba pilgrims consulting for respiratory symptoms in October 2020. Travel Med Infect Dis. 2021 Jan-Feb; 39:101916. PMID: 33189885.
      Citations:    Fields:    Translation:Humans
    38. Ly TDA, Zanini D, Laforge V, Arlotto S, Gentile S, Mendizabal H, Finaud M, Morel D, Quenette O, Malfuson-Clot-Faybesse P, Midejean A, Le-Dinh P, Daher G, Labarriere B, Morel-Roux AM, Coquet A, Augier P, Parola P, Chabriere E, Raoult D, Gautret P. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. Int J Antimicrob Agents. 2020 Dec; 56(6):106219. PMID: 33189890.
      Citations: 18     Fields:    Translation:Humans
    39. Edouard S, Colson P, Melenotte C, Di Pinto F, Thomas L, La Scola B, Million M, Tissot-Dupont H, Gautret P, Stein A, Brouqui P, Parola P, Lagier JC, Raoult D, Drancourt M. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371. PMID: 33179133.
      Citations: 14     Fields:    Translation:Humans
    40. Hoang VT, Gautret P, Memish ZA, Al-Tawfiq JA. Hajj and Umrah Mass Gatherings and COVID-19 Infection. Curr Trop Med Rep. 2020 Nov 03; 1-8. PMID: 33169095.
      Citations: 6     
    41. Leger T, Jacquier A, Barral PA, Castelli M, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Bartoli A, Gaubert JY, Habert P. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407. PMID: 33141845.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    42. Brouqui P, Amrane S, Million M, Cortaredona S, Parola P, Lagier JC, Raoult D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238. PMID: 33130200.
      Citations: 19     Fields:    Translation:Humans
    43. Hoang VT, Al-Tawfiq JA, Gautret P. The Tokyo Olympic Games and the Risk of COVID-19. Curr Trop Med Rep. 2020; 7(4):126-132. PMID: 33145147.
      Citations: 4     
    44. Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021 Jan; 40(1):13-25. PMID: 33113040.
      Citations: 28     Fields:    Translation:Humans
    45. El Vally A, Bollahi MA, Ould Ahmedou Salem MS, Deida J, Parola P, Basco L, El Bara A, Ouldabdallahi M, Ould Mohamed Salem Boukhary A. Retrospective overview of a COVID-19 outbreak in Mauritania. New Microbes New Infect. 2020 Nov; 38:100788. PMID: 33082959.
      Citations:    
    46. Gautret P, Colson P, Lagier JC, Camoin-Jau L, Giraud-Gatineau A, Boudjema S, Finance J, Chaudet H, Raoult D. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19. PMID: 33038556.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    47. Gautret P, Goumballa N, Hoang VT, Sokhna C. The 2020 Grand Magal of Touba, Senegal in the time of the COVID-19 pandemic. Travel Med Infect Dis. 2020 Nov - Dec; 38:101880. PMID: 32949701.
      Citations: 1     Fields:    Translation:Humans
    48. Boudjema S, Finance J, Coulibaly F, Meddeb L, Tissot-Dupont H, Michel M, Lagier JC, Million M, Radulesco T, Michel J, Brouqui P, Raoult D, Fenollar F, Parola P. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875. PMID: 32898703.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    49. Colson P, Tissot-Dupont H, Morand A, Boschi C, Ninove L, Esteves-Vieira V, Gautret P, Brouqui P, Parola P, Lagier JC, Zandotti C, Million M, La Scola B, Raoult D. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987. PMID: 32845413.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    50. Aherfi S, Gautret P, Chaudet H, Raoult D, La Scola B. Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020. Int J Infect Dis. 2020 Nov; 100:88-94. PMID: 32829043.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    51. Dao TL, Hoang VT, Ly TDA, Goumballa N, Courjon J, Memish Z, Sokhna C, Raoult D, Parola P, Gautret P. Epidemiology of human common coronavirus acquisition in pilgrims. Travel Med Infect Dis. 2020 Sep - Oct; 37:101845. PMID: 32805418.
      Citations:    Fields:    Translation:HumansCells
    52. Gautret P, Raoult D. Nullane salus extra ecclesiam. New Microbes New Infect. 2020 Sep; 37:100714. PMID: 32834899.
      Citations: 1     
    53. Hoang VT, Dao TL, Gautret P. Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. J Med Virol. 2020 11; 92(11):2366-2367. PMID: 32449789.
      Citations: 39     Fields:    Translation:Humans
    54. Sokhna C, Mboup BM, Goumbala N, Dieng M, Sylla AB, Raoult D, Parola P, Gautret P. Establishing Medical Coverage and Epidemiological Surveillance during the Grand Magal of Touba in Senegal: A Public Health Need. J Epidemiol Glob Health. 2020 12; 10(4):247-249. PMID: 32959622.
      Citations:    Fields:    Translation:HumansPHPublic Health
    55. Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791. PMID: 32593867.
      Citations: 103     Fields:    Translation:HumansCellsPHPublic Health
    56. Million M, Gautret P, Colson P, Roussel Y, Dubourg G, Chabriere E, Honore S, Rolain JM, Fenollar F, Fournier PE, Lagier JC, Parola P, Brouqui P, Raoult D. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709. PMID: 33088574.
      Citations: 26     
    57. Al-Tawfiq JA, Garout MA, Gautret P. Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2. Infez Med. 2020 Jun 01; 28(suppl 1):64-70. PMID: 32532941.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    58. Gautret P, Colson P, Lagier JC, Parola P, Raoult D. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759. PMID: 32492484.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    59. Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, Aubry C, Correard F, Giraud-Gatineau A, Roussel Y, Berenger C, Cassir N, Seng P, Zandotti C, Dhiver C, Ravaux I, Tomei C, Eldin C, Tissot-Dupont H, Honoré S, Stein A, Jacquier A, Deharo JC, Chabrière E, Levasseur A, Fenollar F, Rolain JM, Obadia Y, Brouqui P, Drancourt M, La Scola B, Parola P, Raoult D. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738. PMID: 32387409.
      Citations: 169     Fields:    Translation:HumansCellsPHPublic Health
    60. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, Gautret P, Raoult D. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061. PMID: 32342252.
      Citations: 241     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    61. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M, Eldin C, Finance J, Vieira VE, Tissot-Dupont HT, Honoré S, Stein A, Million M, Colson P, La Scola B, Veit V, Jacquier A, Deharo JC, Drancourt M, Fournier PE, Rolain JM, Brouqui P, Raoult D. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663. PMID: 32289548.
      Citations: 282     Fields:    Translation:HumansCellsPHPublic Health
    62. Schlagenhauf P, Grobusch MP, Maier JD, Gautret P. Repurposing antimalarials and other drugs for COVID-19. Travel Med Infect Dis. 2020 Mar - Apr; 34:101658. PMID: 32247925.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    63. Eldin C, Lagier JC, Mailhe M, Gautret P. Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France. Travel Med Infect Dis. 2020 May - Jun; 35:101643. PMID: 32247016.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    64. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949. PMID: 32205204.
      Citations: 1940     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    65. Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, Dudouet P, Ormières E, Ailhaud L, Parola P, Lagier JC, Brouqui P, Zandotti C, Ninove L, Luciani L, Boschi C, La Scola B, Raoult D, Million M, Colson P, Gautret P. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632. PMID: 32205269.
      Citations: 51     Fields:    Translation:HumansCellsPHPublic Health
    66. Lagier JC, Colson P, Tissot Dupont H, Salomon J, Doudier B, Aubry C, Gouriet F, Baron S, Dudouet P, Flores R, Ailhaud L, Gautret P, Parola P, La Scola B, Raoult D, Brouqui P. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624. PMID: 32179125.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    67. Gautret P, Al-Tawfiq JA, Hoang VT. COVID 19: Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? Travel Med Infect Dis. 2020 Mar - Apr; 34:101622. PMID: 32171882.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    68. Hoang VT, Ali-Salem S, Belhouchat K, Meftah M, Sow D, Dao TL, Ly TDA, Drali T, Ninove L, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Respiratory tract infections among French Hajj pilgrims from 2014 to 2017. Sci Rep. 2019 11 28; 9(1):17771. PMID: 31780750.
      Citations: 9     Fields:    Translation:Humans
    69. Hoang VT, Sow D, Belhouchat K, Dao TL, Ly TDA, Fenollar F, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Environmental investigation of respiratory pathogens during the Hajj 2016 and 2018. Travel Med Infect Dis. 2020 Jan - Feb; 33:101500. PMID: 31600567.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    70. Hoang VT, Goumballa N, Dao TL, Ly TDA, Ninove L, Ranque S, Raoult D, Parola P, Sokhna C, Pommier de Santi V, Gautret P. Respiratory and gastrointestinal infections at the 2017 Grand Magal de Touba, Senegal: A prospective cohort survey. Travel Med Infect Dis. 2019 May 03; 101410. PMID: 31048009.
      Citations: 9     Fields:    
    71. Hoang VT, Sow D, Dogue F, Edouard S, Drali T, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Acquisition of respiratory viruses and presence of respiratory symptoms in French pilgrims during the 2016 Hajj: A prospective cohort study. Travel Med Infect Dis. 2019 Jul - Aug; 30:32-38. PMID: 30858034.
      Citations: 7     Fields:    Translation:HumansCells
    72. Hoang VT, Dao TL, Ly TDA, Belhouchat K, Chaht KL, Gaudart J, Mrenda BM, Drali T, Yezli S, Alotaibi B, Fournier PE, Raoult D, Parola P, de Santi VP, Gautret P. The dynamics and interactions of respiratory pathogen carriage among French pilgrims during the 2018 Hajj. Emerg Microbes Infect. 2019; 8(1):1701-1710. PMID: 31749410.
      Citations: 8     Fields:    Translation:HumansCells
    73. Al-Tawfiq JA, Gautret P. Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review. Travel Med Infect Dis. 2019 Jan - Feb; 27:27-32. PMID: 30550839.
      Citations: 40     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    74. Hoang VT, Gautret P. Infectious Diseases and Mass Gatherings. Curr Infect Dis Rep. 2018 Aug 28; 20(11):44. PMID: 30155747.
      Citations: 24     
    75. Alfaraj SH, Al-Tawfiq JA, Gautret P, Alenazi MG, Asiri AY, Memish ZA. Evaluation of visual triage for screening of Middle East respiratory syndrome coronavirus patients. New Microbes New Infect. 2018 Nov; 26:49-52. PMID: 30224971.
      Citations: 5     
    76. Griffiths K, Charrel R, Lagier JC, Nougairede A, Simon F, Parola P, Brouqui P, Gautret P. Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study. Travel Med Infect Dis. 2016 Jul-Aug; 14(4):414-6. PMID: 27185404.
      Citations: 8     Fields:    Translation:HumansCells
    77. Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. The spectrum of respiratory pathogens among returning Hajj pilgrims: myths and reality. Int J Infect Dis. 2016 Jun; 47:83-5. PMID: 26845442.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    78. Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. Hajj-associated viral respiratory infections: A systematic review. Travel Med Infect Dis. 2016 Mar-Apr; 14(2):92-109. PMID: 26781223.
      Citations: 31     Fields:    Translation:HumansCells
    79. Memish ZA, Assiri A, Turkestani A, Yezli S, Al Masri M, Charrel R, Drali T, Gaudart J, Edouard S, Parola P, Gautret P. Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect. 2015 Jun; 21(6):571.e1-8. PMID: 25700892.
      Citations: 39     Fields:    Translation:Humans
    80. Sridhar S, Brouqui P, Parola P, Gautret P. Imported cases of Middle East respiratory syndrome: an update. Travel Med Infect Dis. 2015 Jan-Feb; 13(1):106-9. PMID: 25477148.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    81. Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, Memish ZA, Al Masri M, Fournier PE, Raoult D, Brouqui P, Parola P, Gautret P. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov; 20(11):1821-7. PMID: 25341199.
      Citations: 43     Fields:    Translation:HumansCellsPHPublic Health
    82. Al-Tawfiq JA, Zumla A, Gautret P, Gray GC, Hui DS, Al-Rabeeah AA, Memish ZA. Surveillance for emerging respiratory viruses. Lancet Infect Dis. 2014 Oct; 14(10):992-1000. PMID: 25189347.
      Citations: 38     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    83. Gautret P, Gray GC, Charrel RN, Odezulu NG, Al-Tawfiq JA, Zumla A, Memish ZA. Emerging viral respiratory tract infections--environmental risk factors and transmission. Lancet Infect Dis. 2014 Nov; 14(11):1113-1122. PMID: 25189350.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    84. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, Al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30. PMID: 24656283.
      Citations: 41     Fields:    Translation:HumansCells
    85. Gautret P, Benkouiten S, Salaheddine I, Belhouchat K, Drali T, Parola P, Brouqui P. Hajj pilgrims knowledge about Middle East respiratory syndrome coronavirus, August to September 2013. Euro Surveill. 2013 Oct 10; 18(41):20604. PMID: 24135123.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    86. Gautret P, Benkouiten S, Salaheddine I, Parola P, Brouqui P. Preventive measures against MERS-CoV for Hajj pilgrims. Lancet Infect Dis. 2013 Oct; 13(10):829-31. PMID: 24070554.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    87. Gautret P. Middle East Respiratory Syndrome (MERS) coronavirus. What travel health advice should be given to Hajj pilgrims? Travel Med Infect Dis. 2013 Sep-Oct; 11(5):263-5. PMID: 24055442.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    88. Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, Zandotti C, Memish ZA, al Masri M, Gaillard C, Brouqui P, Parola P. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013 Jul; 19(7):E315-7. PMID: 23452263.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    89. Rodrigues R, Telles JN, Essere K, Ducournau C, Roqueplo C, Levieuge A, Davoust B, Parola P, Paranhos-Baccalà G, Peyrefitte CN. Development of a one step real time RT-PCR assay to detect and quantify Dugbe virus. J Virol Methods. 2011 Sep; 176(1-2):74-7. PMID: 21703306.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    Gautret's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (597)
    Explore
    _
    Co-Authors (208)
    Explore
    _
    Similar People (60)
    Explore
    _